Human Gut Microbiome Development Clinical Trial
— METAKIDSOfficial title:
Phages Dynamics and Influences During Human Gut Microbiome Establishment
| Verified date | July 2019 |
| Source | Institut Pasteur |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Microbial communities are key components of human environment. Consequently, human gut microbiome have been extensively studied providing a better understanding of the relations between bacterial populations and host physiology. However, a typical analysis tends to elude the complexity of the mixes in term of species, strains, as well as extra-chromosomal DNA molecules such as and phages. MetaKids project aims at bringing, at an unprecedented resolution, a new view of those populations and the internal relationships during human gut establishment, a crucial step with long-term impacts on host health. This project relies on the ability of Meta3C, a newly technique developed in the lab, to identify the bacterial host genomes of the different phages the investigators will detect thanks to the physical collision these molecules experience. Given the role that human gut phages may play in shaping the development of host microbiomes, their potential for application is of great interest.
| Status | Terminated |
| Enrollment | 19 |
| Est. completion date | December 31, 2018 |
| Est. primary completion date | December 31, 2018 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 10 Weeks to 9 Months |
| Eligibility |
Inclusion Criteria: 1. Child attending at least 4 days a week one of the two municipal municipal nursery (crèches) in the town of Orsay (91, France); 2. Aged less than 9 months at the time of entry to the crèche (August-October 2017); 3. Parent (s) / legal representative not opposed to the child's participation in the research; Exclusion Criteria: - Toilet training; - Prematurity; - Participation in clinical research requiring the use of a drug. |
| Country | Name | City | State |
|---|---|---|---|
| France | Crèche du Parc | Orsay | Essonne |
| France | Crèche La Farandole | Orsay | Essonne |
| Lead Sponsor | Collaborator |
|---|---|
| Institut Pasteur | City of Orsay |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Characterization of phages and bacteria genomes during infant gut development. | Genomic reconstruction and characterization of the different genomes (phages, bacteria, yeast) present in the human gut during the three first years of life. This outcomes will provide a large catalog of DNA sequences. | 3 years | |
| Primary | Characterization of phages and bacteria abundance and variations during infant gut development | Characterization of the variation of the different species present in human gut during the 3 first years of life. This outcomes will provide access to the dynamics of the different species present during this period and possibility to correlate them with environmental variation (dietary, age) | 3 years | |
| Primary | Characterization of phages-bacteria interactions | Phages are the major predator of bacteria but their role during human gut establishment remains poorly characterized. This catalog of interactions will allow to understand the role of the phages during human gut development | 3 years | |
| Secondary | Characterization of phages and bacteria variations in response to environmental perturbations during infant gut development | Characterization of the small variations of the different species present in human gut during the 3 first years of life in response to environmental perturbations. This outcome will provide access to the dynamics of the different species present during this period and possibility to correlate them with environmental perturbations (antibiotic, vaccine, illness). | 2 to 3 weeks |